Evidence map›Paper›PMID 31675957›Full record

ArticleBMC health services research2019

Effectiveness and cost-effectiveness of a multicomponent intervention to implement a clinical practice guideline for systemic lupus erythematosus: protocol for a cluster-randomized controlled trial.

María M Trujillo-Martín, Yolanda Ramallo-Fariña, Tasmania Del Pino-Sedeño, Íñigo Rúa-Figueroa, Elisa Trujillo-Martín, Laura Vallejo-Torres, Iñaki Imaz-Iglesia, Ricardo Sánchez-de-Madariaga, Ana M de Pascual-Medina, Pedro Serrano-Aguilar and 1 more

Registry-linked trialAbstract readClinical Trial Protocol
In one paragraph

Article in BMC health services research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03537638 (Effectiveness and Cost-effectiveness of a Multicomponent Strategy to Implement a Clinical Practice Guideline and Improve Health Outcomes in People With Systemic Lupus Erythematosus), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03537638 nacompletednot on this map

Effectiveness and Cost-effectiveness of a Multicomponent Strategy to Implement a Clinical Practice Guideline and Improve Health Outcomes in People With Systemic Lupus Erythematosus

TypeinterventionalSponsorServicio Canario de SaludRan2018 to 2020Enrolled237ConditionsSystemic Lupus ErythematosusArmsMulticomponent intervention
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

María M Trujillo-MartínFundación Canaria Instituto de Investigación Sanitaria de Canarias (FIISC), Santa Cruz de Tenerife, Tenerife, Spain. mar.trujillomartin@sescs.es.
Yolanda Ramallo-FariñaFundación Canaria Instituto de Investigación Sanitaria de Canarias (FIISC), Santa Cruz de Tenerife, Tenerife, Spain.
Tasmania Del Pino-SedeñoFundación Canaria Instituto de Investigación Sanitaria de Canarias (FIISC), Santa Cruz de Tenerife, Tenerife, Spain.
Íñigo Rúa-FigueroaServicio de Reumatología, Hospital Universitario de Gran Canaria Dr. Negrin, Las Palmas de Gran Canaria, Spain.
Elisa Trujillo-MartínServicio de Reumatología, Hospital Universitario de Canarias, La Laguna, Spain.
Laura Vallejo-TorresDepartamento de Métodos Cuantitativos en Economía y Gestión, Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain.
Iñaki Imaz-IglesiaRed de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC), Madrid, Spain.
Ricardo Sánchez-de-MadariagaRed de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC), Madrid, Spain.
Ana M de Pascual-MedinaServicio de Evaluación del Servicio Canario de la Salud (SESCS), Servicio Canario de la Salud, Santa Cruz de Tenerife, Spain.
Pedro Serrano-AguilarRed de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC), Madrid, Spain.
SLE-CPG-Implementation Group

Funding

Instituto de Salud Carlos III PI12/01348
6 · The paper itself

Abstract

backgroundSystemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease with significant potential morbidity and mortality. Substantial gaps have been documented between the development and dissemination of clinical practice guidelines (CPG) and their implementation in practice. The aim of this study is to assess the effectiveness and cost-effectiveness of a multi-component knowledge transfer intervention to implement a CPG for the management of SLE (CPG-SLE).

methodsThe study is an open, multicentre, controlled trial with random allocation by clusters to intervention or control. Clusters are four public university hospitals of the Canary Islands Health Service where rheumatologists are invited to participate. Patients diagnosed with SLE at least one year prior to recruitment are selected. Rheumatologists in intervention group receive a short educational group programme to both update their knowledge about SLE management according to CPG-SLE recommendations and to acquire knowledge and training on use of the patient-centred approach, a decision support tool embedded in the electronic clinical record and a quarterly feedback report containing information on management of SLE patients. Primary endpoint is change in self-perceived disease activity. Secondary endpoints are adherence of professionals to CPG-SLE recommendations, health-related quality of life, patient perception of their participation in decision making, attitudes of professionals towards shared decision making, knowledge of professionals about SLE and use of healthcare resources. Calculated sample size is 412 patients. Data will be collected from questionnaires and clinical records. Length of follow-up will be 18 months. Multilevel mixed models with repeated time measurements will be used to analyze changes in outcomes over time. Cost-effectiveness, from both social and healthcare services perspectives, will be analyzed by measuring effectiveness in terms of quality-adjusted life years gained. Deterministic and probabilistic sensitivity analyses are planned. DISCUSSION: Impact of CPGs in clinical practice could be improved by applying proven value interventions to implement them. The results of this ongoing trial are expected to generate important scientifically valid and reproducible information not only on clinical effectiveness but also on cost-effectiveness of a multi-component intervention for implementation of a CPG based on communication technologies for chronic patients in the hospital setting.

trial registrationClinicalTrial.gov NCT03537638 . Registered on 25 May 2018.

Indexed as

Health Knowledge, Attitudes, PracticePractice Guidelines as TopicCost-Benefit AnalysisHospitals, PublicHumansLupus Erythematosus, SystemicMulticenter Studies as TopicProgram EvaluationRandomized Controlled Trials as TopicResearch DesignRheumatologistsSpainTreatment OutcomeCare managementClinical practice guidelineCost-effectivenessDecision support aidsElectronic communicationImplementationKnowledge transferMulticomponent interventionSecondary careSystemic lupus erythematosus

Identifiers

PMID31675957
PMCPMC6824022

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.